Navigation Links
Human umbilical cord blood cell co-culture supports embryonic stem cell expansion
Date:11/15/2012

Putnam Valley, NY. (Nov. 15, 2012) Researchers in Taiwan have developed a "safe, feasible and robust co-culture system" supplied by human umbilical cord mensenchymal stem cells (HUCMSCs) to feed the sustained culture used for human embryonic stem cell (hESC) expansion prior to cell transplantation. The co-culture, said the researchers, "appears to eliminate the most feared characteristic of transplanted hESCs," which is their propensity to form tumors.

The study, published in the current issue of CELL TRANSPLANTATION, is now freely available on-line at http://www.ingentaconnect.com/content/cog/ct/.

"Embryonic stem cells have pluripotent potential," said study co-author Dr. Tang-Yuan Chu of the Buddhist Tzu Chi General Hospital at Tzu Chi University in Hualien, Taiwan. "The sustained maintenance of hESCs depends on a co-culture with an animal based "feeder" that can create the risk for transmitting nonhuman materials and unknown pathogens. To solve this problem, human tissues have been used as feeders."

The expansion of pluripotent hESCs traditionally requires a feeder culture, meaning that a variety of animal and human tissues have been used in feeder cultures.

The researchers note that while hESCs have been successfully co-cultured using human fetal muscle and skin cells, adult fallopian tube epithelial cells, foreskin cells, and bone marrow stem cells, their study used hUCMScs to create a co-culture. They said that using hUCMSCs as a source feeder has several advantages, including their wide availability, ease of handling and low immunogenicity.

However, according to the researchers, when using various mouse or primate tissues, and even when using human tissues for co-cultures, tumor-like formations called "teratomas" - growths containing tissues belonging to all three germ layers - often form. Although undesirable, teratomas have been used as a marker for the ability of stem cells to be able to develop pluripotency.

This study demonstrated that pluripotency development need not necessarily be teratoma forming.

"We suggest that the feeder we developed from hUCMSCs may support the transition of hESCs that does not grow teratomas because, unlike tissue sources for other feeders, by using hUCMSCs we did not use material comprised of all three germ layers," said the researchers.

"In addition to eliminating teratomas, the proposed system also significantly reduces the workload involved in the preparation of new feeder lines," they concluded.


'/>"/>

Contact: Robert Miranda
cogcomm@aol.com
Cell Transplantation Center of Excellence for Aging and Brain Repair
Source:Eurekalert

Related medicine news :

1. Sociology, economics researchers receive grant to study development across the human lifespan
2. Gut Bacteria Often Similar in Humans, Chimps: Study
3. First trial in humans of minicells: A completely new way of delivering anti-cancer drugs
4. Testing pain killers on humans could save money and speed the arrival of new drugs
5. New, improved mouse model of human Alzheimers may enable drug discovery
6. Spread of human melanoma cells in mice correlates with clinical outcomes in patients
7. First gene therapy study in human salivary gland shows promise
8. Clinical trials for first-ever human hookworm vaccine advance
9. Bigger human genome pool uncovers rarer variants
10. A Viagra follow-up? Drug used to treat glaucoma actually grows human hair
11. Genes of Africas Khoe-San Peoples Give Clues to Human Evolution
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/1/2017)... ... , ... Breast Surgeon, Dr. Dennis Holmes of 90210 Surgery Medical Center will ... it fits in the treatment paradigm at Susan G. Komen San Diego’s Annual Dinner ... leading cancer and wellness experts to share the latest innovations in breast cancer research, ...
(Date:3/1/2017)... ... 2017 , ... Award-winning medical group Allied Anesthesia today announced that, as of ... averaging more than one trip per year since 1998. Char was named the Los ... the details of his charitable work. Char has been an Allied Anesthesiologist since 2000. ...
(Date:3/1/2017)... (PRWEB) , ... March 01, 2017 , ... ... pledge to help increase colorectal cancer screening rates by supporting the 80% by ... Control and Prevention (CDC) and the National Colorectal Cancer Roundtable (an organization co-founded ...
(Date:3/1/2017)... ... March 01, 2017 , ... March 2017 – All year ... people don’t want to stop training to brave the cold weather, snow or ice. ... a small incline can help protect these vulnerable joints, says orthopaedic surgeon Kevin D. ...
(Date:3/1/2017)... , ... March 01, 2017 , ... “There is Comfort ... she gave to the author in their all-too-brief time together, and the soul-healing comfort ... the Soul” is the creation of published author, Jerie A. Tau, a dog-loving medical ...
Breaking Medicine News(10 mins):
(Date:3/1/2017)... BRENTWOOD, Tenn. , March 1, 2017  Numotion, ... has announced the availability of Tek RMD ("robotic mobilization ... States . Tek RMD is a motorized standing ... are in a manual wheelchair to complete everyday activities ... board and control a Tek RMD unassisted. Numotion is ...
(Date:3/1/2017)... ... Research and Markets has announced the addition of the ... The Global Infertility Therapy Partnering Terms and Agreements ... agreements entered into by the world,s leading healthcare companies. ... deals are discovery or development stage whereby the licensee obtains a ...
(Date:3/1/2017)... MUMBAI, India and PRINCETON, ... Pharmaceutical Industries Ltd (Reuters: SUN.BO, Bloomberg: SUNP IN, ... its subsidiaries or associate companies) today announced that ... Phase-3 clinical trials (reSURFACE 1 and 2) of ... the treatment of moderate-to-severe plaque psoriasis, will be ...
Breaking Medicine Technology: